Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: Selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels

Hypertension

Volumn 60, Issue 5, 2012, Pages 1220-1225

  Fok, Henry ^a   Jiang, Benyu ^a   Clapp, Brian ^b   Chowienczyk, Phil ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

adrenergic antagonists; brain natriuretic peptide; calcium channel antagonists; conduit arteries; cyclic guanosine monophosphate; nitric oxide; nitroglycerin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GLYCERYL TRINITRATE; HYDRALAZINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENTOLAMINE; VERAPAMIL;

ADULT; ARTERY; ARTERY DIAMETER; ARTERY DILATATION; ARTERY TONE; ARTICLE; BLOOD FLOW; BLOOD PRESSURE CUFF; BLOOD VESSEL TONE; BRACHIAL ARTERY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ECHOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MUSCULAR CONDUIT ARTERY; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; REGULATORY MECHANISM; RESISTANCE BLOOD VESSEL; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; FOREARM; HUMANS; HYDRALAZINE; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NATRIURETIC PEPTIDE, BRAIN; NITRIC OXIDE DONORS; NITROGLYCERIN; NITROPRUSSIDE; PHENTOLAMINE; PULSE WAVE ANALYSIS; RADIAL ARTERY; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS; VERAPAMIL; YOUNG ADULT;

EID: 84868201435     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.198788     Document Type: Article

References (22)

1. Franklin SS, Lopez VA, Wong ND, Mitchell GF, Larson MG, Vasan RS, Levy D. Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation. 2009;119:243-250.
2. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I-aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
3. Laurent S, Boutouyrie P. Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension. 2007;49:1202-1206.
4. Stewart AD, Millasseau SC, Kearney MT, Ritter JM, Chowienczyk PJ. Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans. Hypertension. 2003;42:915-918.
5. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107:2864-2869.
6. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865-1871.
7. Kurz MA, Lamping KG, Bates JN, Eastham CL, Marcus ML, Harrison DG. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ Res. 1991;68:847-855.
8. Mitchell GF, Lacourcière Y, Ouellet JP, Izzo JL Jr, Neutel J, Kerwin LJ, Block AJ, Pfeffer MA. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation. 2003;108:1592-1598.
9. Zolle O, Lawrie AM, Simpson AW. Activation of the particulate and not the soluble guanylate cyclase leads to the inhibition of Ca2+ extrusion through localized elevation of cGMP. J Biol Chem. 2000;275:25892-25899.
10. Su J, Scholz PM, Weiss HR. Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes. Exp Biol Med (Maywood). 2005;230:242-250.
11. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev. 1999;79:387-423.
12. Wellman GC, Bonev AD, Nelson MT, Brayden JE. Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels. Circ Res. 1996;79:1024-1030.
13. Kinlay S, Creager MA, Fukumoto M, Hikita H, Fang JC, Selwyn AP, Ganz P. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension. 2001;38:1049-1053.
14. Bank AJ, Kaiser DR, Rajala S, Cheng A. In vivo human brachial artery elastic mechanics: effects of smooth muscle relaxation. Circulation. 1999;100:41-47.
15. Bank AJ, Wang H, Holte JE, Mullen K, Shammas R, Kubo SH. Contribution of collagen, elastin, and smooth muscle to in vivo human brachial artery wall stress and elastic modulus. Circulation. 1996;94:3263-3270.
16. Pauca AL, Kon ND, O'Rourke MF. Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries. Heart. 2005;91:1428-1432.
17. Westerhof N, O'Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens. 1995;13:943-952.
18. Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Mang K, Morgan JJ, Avolio AP. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J. 1990;11:138-144.
19. Duchier J, Iannascoli F, Safar M. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am J Cardiol. 1987;60:99-102.
20. Stokes GS, Bune AJ, Huon N, Barin ES. Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension. Hypertension. 2005;45:380-384.
21. Cecelja M, Jiang B, Spector TD, Chowienczyk P. Progression of central pulse pressure over 1 decade of aging and its reversal by nitroglycerin a twin study. J Am Coll Cardiol. 2012;59:475-483.
22. Van Bortel LM, Spek JJ, Balkestein EJ, Sardina M, Struijker Boudier HA. Is it possible to develop drugs that act more selectively on large arteries? J Hypertens. 1999;17:701-705.